Evidence map›Paper›PMID 23547259›Full record

ArticleMolecular and cellular biology2013

Inactivation of the mTORC1-eukaryotic translation initiation factor 4E pathway alters stress granule formation.

Marie-Josée Fournier, Laetitia Coudert, Samia Mellaoui, Pauline Adjibade, Cristina Gareau, Marie-France Côté, Nahum Sonenberg, René C Gaudreault, Rachid Mazroui

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 82 citations in OpenAlex.

  1. The Role of Long Noncoding RNAs in Modulation of Stress Granules in Cancer.Journal of cellular and molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Connecting the Dots: Stress Granule and Cardiovascular Diseases.Journal of cardiovascular translational research · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Stress Granules in Cancer.Reviews of physiology, biochemistry and pharmacology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Marie-Josée FournierDepartment of Molecular Biology, Laval University, Canada .
Laetitia Coudert
Samia Mellaoui
Pauline Adjibade
Cristina Gareau
Marie-France Côté
Nahum Sonenberg
René C Gaudreault
Rachid Mazroui
Université Laval · CAMcGill University · CA

Funding

Canadian Institutes of Health Research MOP-79334Canadian Institutes of Health Research MOP-GF091050Canadian Institutes of Health Research MOP-IC093226-CBT
6 · The paper itself

Abstract

Stress granules (SG) are cytoplasmic multimeric RNA bodies that form under stress conditions known to inhibit cap-dependent translation. SG contain translation initiation factors, RNA binding proteins, and signaling molecules. SG are known to inhibit apoptotic pathways, thus contributing to chemo- and radioresistance in tumor cells. However, whether stress granule formation involves oncogenic signaling pathways is currently unknown. Here, we report a novel role of the mTORC1-eukaryotic translation initiation factor 4E (eIF4E) pathway, a key regulator of cap-dependent translation initiation of oncogenic factors, in SG formation. mTORC1 specifically drives the eIF4E-mediated formation of SG through the phosphorylation of 4E-BP1, a key factor known to inhibit formation of the mTORC1-dependent eIF4E-eIF4GI interactions. Disrupting formation of SG by inactivation of mTOR with its specific inhibitor pp242 or by depletion of eIF4E or eIF4GI blocks the SG-associated antiapoptotic p21 pathway. Finally, pp242 sensitizes cancer cells to death in vitro and inhibits the growth of chemoresistant tumors in vivo. This work therefore highlights a novel role of the oncogenic mTORC1-eIF4E pathway, namely, the promotion of formation of antiapoptotic SG.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBoronic AcidsBortezomibCell Cycle ProteinsChick EmbryoCytoplasmic GranulesEukaryotic Initiation Factor-4EHeLa CellsHumansIndolesMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphoproteinsPhosphorylationPurinesAdaptor Proteins, Signal TransducingBoronic AcidsBortezomibCell Cycle ProteinsEIF4EBP1 protein, humanEukaryotic Initiation Factor-4EIndolesMechanistic Target of Rapamycin Complex 1MTOR protein, humanMultiprotein ComplexesPhosphoproteinsPP242PurinesPyrazinesTOR Serine-Threonine Kinases

Identifiers

PMID23547259
PMCPMC3648080
OpenAlexW2115880540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.